Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Opyl Ltd. ( (AU:OPL) ) has provided an update.
Opyl Ltd. has introduced TrialKey, an AI-driven analysis tool that assesses 1,300+ variables to predict clinical trial success with over 92% accuracy, aiming to improve trial designs. This innovation positions the company to capitalize on a vast global market, offering significant opportunities in the pharmaceutical and medtech industries, where trial failures are common, potentially generating substantial revenue.
More about Opyl Ltd.
YTD Price Performance: -25.00%
Average Trading Volume: 274,030
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$2.89M
See more insights into OPL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue